Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

USP9X regulates centrosome duplication and promotes breast carcinogenesis.

Li X, Song N, Liu L, Liu X, Ding X, Song X, Yang S, Shan L, Zhou X, Su D, Wang Y, Zhang Q, Cao C, Ma S, Yu N, Yang F, Wang Y, Yao Z, Shang Y, Shi L.

Nat Commun. 2017 Mar 31;8:14866. doi: 10.1038/ncomms14866.

2.

Lesion complexity drives age related cancer susceptibility in human mammary epithelial cells.

Sridharan DM, Enerio S, LaBarge MA, Stampfer MM, Pluth JM.

Aging (Albany NY). 2017 Feb 28;9(3):665-686. doi: 10.18632/aging.101183.

3.

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.

Castellano L, Dabrowska A, Pellegrino L, Ottaviani S, Cathcart P, Frampton AE, Krell J, Stebbing J.

Nucleic Acids Res. 2017 May 5;45(8):4401-4412. doi: 10.1093/nar/gkx022.

4.

Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.

Ho SM, Rao R, To S, Schoch E, Tarapore P.

Endocr Relat Cancer. 2017 Feb;24(2):83-96. doi: 10.1530/ERC-16-0175. Epub 2016 Dec 20.

PMID:
27998958
5.

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers.

Mahathre MM, Rida PC, Aneja R.

J Biomed Res. 2016 Nov;30(6):441-451. doi: 10.7555/JBR.30.20150109. Epub 2015 Nov 10. Review.

6.

The PLK4-STIL-SAS-6 module at the core of centriole duplication.

Arquint C, Nigg EA.

Biochem Soc Trans. 2016 Oct 15;44(5):1253-1263. Review.

7.

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy.

Zhang W, Mao JH, Zhu W, Jain AK, Liu K, Brown JB, Karpen GH.

Nat Commun. 2016 Aug 31;7:12619. doi: 10.1038/ncomms12619.

8.

Opposing post-translational modifications regulate Cep76 function to suppress centriole amplification.

Barbelanne M, Chiu A, Qian J, Tsang WY.

Oncogene. 2016 Oct 13;35(41):5377-5387. doi: 10.1038/onc.2016.74. Epub 2016 Apr 11.

10.

Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.

Denu RA, Zasadil LM, Kanugh C, Laffin J, Weaver BA, Burkard ME.

BMC Cancer. 2016 Jan 29;16:47. doi: 10.1186/s12885-016-2083-x.

11.

Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse.

Coelho PA, Bury L, Shahbazi MN, Liakath-Ali K, Tate PH, Wormald S, Hindley CJ, Huch M, Archer J, Skarnes WC, Zernicka-Goetz M, Glover DM.

Open Biol. 2015 Dec;5(12):150209. doi: 10.1098/rsob.150209.

12.

Chronic centrosome amplification without tumorigenesis.

Vitre B, Holland AJ, Kulukian A, Shoshani O, Hirai M, Wang Y, Maldonado M, Cho T, Boubaker J, Swing DA, Tessarollo L, Evans SM, Fuchs E, Cleveland DW.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):E6321-30. doi: 10.1073/pnas.1519388112. Epub 2015 Nov 2.

13.
14.

How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.

Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R.

Cancer Metastasis Rev. 2015 Dec;34(4):703-13. doi: 10.1007/s10555-015-9590-0. Review.

15.

Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress.

Domínguez D, Feijoo P, Bernal A, Ercilla A, Agell N, Genescà A, Tusell L.

Oncotarget. 2015 Sep 29;6(29):28238-56. doi: 10.18632/oncotarget.4958.

16.

Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.

Haaß W, Kleiner H, Müller MC, Hofmann WK, Fabarius A, Seifarth W.

PLoS One. 2015 Aug 12;10(8):e0133769. doi: 10.1371/journal.pone.0133769. eCollection 2015.

17.

The Aspergillus nidulans bimC4 mutation provides an excellent tool for identification of kinesin-14 inhibitors.

Wang B, Li K, Jin M, Qiu R, Liu B, Oakley BR, Xiang X.

Fungal Genet Biol. 2015 Sep;82:51-5. doi: 10.1016/j.fgb.2015.06.005. Epub 2015 Jun 24.

18.

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.

Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R, Hofmann WK, Fabarius A, Seifarth W; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; German CML Study Group.

PLoS One. 2015 Jun 18;10(6):e0129648. doi: 10.1371/journal.pone.0129648. eCollection 2015.

19.

Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.

McBride M, Rida PC, Aneja R.

Mol Aspects Med. 2015 Nov;45:3-13. doi: 10.1016/j.mam.2015.05.001. Epub 2015 May 27. Review.

20.

Replication stress in Mammalian cells and its consequences for mitosis.

Gelot C, Magdalou I, Lopez BS.

Genes (Basel). 2015 May 22;6(2):267-98. doi: 10.3390/genes6020267. Review.

Supplemental Content

Support Center